Nomura Research Institute, Ltd.
NURAF
$37.72
-$0.88-2.28%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.64% | -1.07% | -6.27% | -5.60% | 1.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.64% | -1.07% | -6.27% | -5.60% | 1.43% |
| Cost of Revenue | 2.54% | -1.63% | -6.59% | -7.45% | 1.02% |
| Gross Profit | 2.84% | -0.04% | -5.69% | -2.04% | 2.18% |
| SG&A Expenses | -1.12% | 0.86% | -9.14% | 0.30% | 1.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -113.40% | -172.53% | -220.71% | -45.29% | -521.43% |
| Total Operating Expenses | 1.17% | -1.42% | -8.55% | -6.04% | 0.22% |
| Operating Income | 10.88% | 0.62% | 6.43% | -3.10% | 7.76% |
| Income Before Tax | 13.52% | 4.82% | 6.17% | -7.94% | 9.47% |
| Income Tax Expenses | 9.70% | -8.24% | -7.86% | 41.19% | -7.99% |
| Earnings from Continuing Operations | 15.40% | 11.39% | 13.71% | -21.42% | 17.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -21.33% | 22.39% | -76.09% | -446.36% | -415.08% |
| Net Income | 15.35% | 11.62% | 13.41% | -22.29% | 16.71% |
| EBIT | 10.88% | 0.62% | 6.43% | -3.10% | 7.76% |
| EBITDA | 7.33% | 0.08% | 2.13% | -4.02% | 6.06% |
| EPS Basic | 16.18% | 13.66% | 16.34% | -19.84% | 19.90% |
| Normalized Basic EPS | 16.53% | 6.94% | -- | -2.09% | 11.93% |
| EPS Diluted | 16.18% | 13.75% | 16.34% | -19.84% | 19.96% |
| Normalized Diluted EPS | 16.59% | 7.04% | -- | -2.14% | 11.99% |
| Average Basic Shares Outstanding | -0.70% | -1.81% | -2.50% | -3.06% | -2.67% |
| Average Diluted Shares Outstanding | -0.73% | -1.86% | -2.54% | -3.02% | -2.71% |
| Dividend Per Share | 14.18% | 17.46% | -- | 12.36% | -- |
| Payout Ratio | -- | -- | -- | -0.94% | -0.12% |